Citation Impact
Citing Papers
Zygomycetes in Human Disease
2000 Standout
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
2012 Standout
Transplantation of human fetal retinal pigment epithelium rescues photoreceptor cells from degeneration in the Royal College of Surgeons rat retina.
1996
The Risk, Prevention, and Outcome of Cytomegalovirus After Pediatric Lung Transplantation
2009
Cancer immunoediting: from immunosurveillance to tumor escape
2002 Standout
Classification and Grading of Gastritis
1996 Standout
Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells
2002
Nocardiosis: Updates and Clinical Overview
2012 Standout
Infection in the Transplanted and Native Lung After Single Lung Transplantation
1993
Nocardia infection in lung transplant recipients
2002
NocardiaInfection in Heart‐Lung Transplant Recipients at Alfred Hospital, Melbourne, Australia, 1989–1998
2000
Cytomegalovirus Prevention in High-risk Lung Transplant Recipients: Comparison of 3- vs 12-Month Valganciclovir Therapy
2009
User-Centered Design and Interactive Health Technologies for Patients
2009 Standout
Cancer in patients on dialysis for end-stage renal disease: an international collaborative study
1999 Standout
Malignancy in organ transplantation:
2002
Molecular histogenesis of posttransplantation lymphoproliferative disorders
2003
Role of AID in Tumorigenesis
2007 StandoutNobel
Nocardiosis: Updated Clinical Review and Experience at a Tertiary Center
2010 Standout
Lifestyle-related factors and environmental agents causing cancer: An overview
2007 StandoutNobel
Definitions of Cytomegalovirus Infection and Disease in Transplant Recipients
2002 Standout
Newer Methods for Diagnosis of Cytomegalovirus Infection
1990
EFFICACY AND COST EFFECTIVENESS OF ORAL GANCICLOVIR IN THE PREVENTION OF CYTOMEGALOVIRUS DISEASE AFTER LUNG TRANSPLANTATION1,2
1999
IMPACT OF CYTOMEGALOVIRUS HYPERIMMUNE GLOBULIN ON OUTCOME AFTER CARDIOTHORACIC TRANSPLANTATION
2001
Incidence and treatment of cancer in transplant recipients
1998
Safety and efficacy of prolonged cytomegalovirus prophylaxis with intravenous ganciclovir in pediatric and young adult lung transplant recipients
2006
An Orthotopic Heart Transplant Recipient with Subacute Meningitis
1991
Prospective cytomegalovirus surveillance in paediatric renal transplant patients
1993
Lung and heart-lung transplantation in children
1997
Posttransplantation lymphoproliferative disorders in pediatric thoracic organ recipients
1997
Infection and Cyclosporine
1989
Gastric mucosal nodules due to cytomegalovirus infection
1989
Combined CMV Prophylaxis Improves Outcome and Reduces the Risk for Bronchiolitis Obliterans Syndrome (BOS) after Lung Transplantation
2006
Nocardial Infections in Bone Marrow Transplant Recipients
1996
Retinitis pigmentosa
2006 Standout
Nocardiosis at the Turn of the Century
2009 Standout
Effect of development of antibodies to hla and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome
1998
Risk Factors, Clinical Characteristics, and Outcome of Nocardia Infection in Organ Transplant Recipients: A Matched Case-Control Study
2007 Standout
Solid-Organ Transplantation in HIV-Infected Patients
2002
Infectious complications in pediatric solid organ transplantation
2003
Cytomegalovirus Replication Within the Lung Allograft Is Associated With Bronchiolitis Obliterans Syndrome
2011
Epstein–Barr virus: 40 years on
2004 Standout
Liver transplantation in patients with HIV infection
2004
Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation
1997
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
Post-operative Nosocomial Infections After Lung and Heart Transplantation
2007
B cells under influence: transformation of B cells by Epstein–Barr virus
2003
Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria
2002 Standout
Extracorporeal Photopheresis in Lung Transplantation
2003
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients
2003 Standout
Effect of Pravastatin on Outcomes after Cardiac Transplantation
1995 Standout
Prospective Study of Sequential Reduction in Immunosuppression, Interferon Alpha-2B, and Chemotherapy for Posttransplantation Lymphoproliferative Disorder
2008
Lymphomas After Solid Organ Transplantation: A Collaborative Transplant Study Report
2004
Infection in Solid-Organ Transplant Recipients
2007 Standout
FK 506 ‘Rescue’ Immunosuppression for Obliterative Bronchiolitis After Lung Transplantation
1997
Respiratory Complications of Cardiac Transplantation
1988
Comparison of 8 vs 15 Days of Antibiotic Therapy for Ventilator-Associated Pneumonia in Adults
2003 Standout
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
The risk of transfusion‐acquired CMV infection in seronegative solid‐organ transplant recipients receiving non‐WBC‐reduced blood components not screened for CMV antibody (1984 to 1996): experience at a single Canadian center
2002
Polyfunctional Cytomegalovirus-Specific Immunity in Lung Transplant Recipients Receiving Valganciclovir Prophylaxis
2011
Infection in Organ-Transplant Recipients
1998 Standout
Cytomegalovirus Infection and Pneumonitis: Impact after Isolated Lung Transplantation
1993
Solid tumors after heart transplantation: Lethality of lung cancer
1995
Epstein–Barr Virus Infection
2000 Standout
Monitoring progress after lung transplantation from home-patient adherence
1996
Toxoplasmosis in Pediatric Recipients of Heart Transplants
1992
Ventilator-associated Pneumonia
2002 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Nocardial Brain Abscess
1994 Standout
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Infectious Complications in Heart Transplant Recipients Receiving Cyclosporine and Corticosteroids
1987
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
The Three Es of Cancer Immunoediting
2004 Standout
Zygomycetes in Human Disease
2000 Standout
Infectious Complications in Heart-Lung Transplantation
1993
Infections in solid-organ transplant recipients
1997
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients
1994
Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro
2003 StandoutNobel
Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts.
1992
The medically important aerobic actinomycetes: epidemiology and microbiology
1994 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Bronchoscopic diagnosis of pneumonia
1994
Roles of Infectious Agents in Atherosclerosis and Restenosis
1997 Standout
Immunological monitoring of lung transplant patients by bronchoalveolar lavage analysis
1992
Use of polymerase chain reaction to provide prognostic information on human cytomegalovirus disease after liver transplantation
1997
Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
2003 Standout
Comparison of PCR, Antigenemia Assay, and Rapid Blood Culture for Detection and Prevention of Cytomegalovirus Disease after Lung Transplantation
2000
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Central Nervous System Infection with Listeria monocytogenes : 33 Yearsʼ Experience at a General Hospital and Review of 776 Episodes from the Literature
1998
Epstein-Barr Virus, Cytomegalovirus, and Other Viral Infections in Children After Liver Transplantatlon
1987
Review of solid-organ transplantation in HIV-infected patients
2003
Brain Abscess Following Marrow Transplantation: Experience at the Fred Hutchinson Cancer Research Center, 1984-1992
1994
Aspergillus fumigatusand Aspergillosis
1999 Standout
Cardiotoxicity of Cancer Therapy
2005
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
2009 StandoutNobel
Nocardia species: host-parasite relationships
1994 Standout
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
Burn Wound Infections
2006 Standout
Practice Guidelines for the Management of Bacterial Meningitis
2004 Standout
Aggressive treatment for postcardiac transplant lymphoproliferation
1995
Cytomegalovirus Infection Is Associated With Cardiac Allograft Rejection and Atherosclerosis
1989
Bronchiolitis Obliterans in Recipients of Single, Double, and Heart-Lung Transplantation
1995
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
1995 Standout
Clinical and Laboratory Features of theNocardiaspp. Based on Current Molecular Taxonomy
2006 Standout
Infection after lung transplantation.
1993
Task force 5: Complications
1993
Cytomegalovirus Antigen Expression, Endothelial Cell Proliferation, and Intimal Thickening in Rat Cardiac Allografts After Cytomegalovirus Infection
1995
Correlation between Viral Loads of Cytomegalovirus in Blood and Bronchoalveolar Lavage Specimens from Lung Transplant Recipients Determined by Histology and Immunohistochemistry
2004
Works of J. S. Dummer being referenced
TRANSPLANTATION IN HIV+ PATIENTS
1990
Central Nervous System Infections in Heart and Heart-Lung Transplant Recipients
1989
Cytomegalovirus disease after heart transplantation: Is acyclovir prophylaxis indicated?
1993
Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression.
1992
Cytomegalovirus infection and survival in lung transplant recipients.
1992
Single lung transplantation: a temporal look at rejection, infection, and survival.
1994
Morbidity of Cytomegalovirus Infection in Recipients of Heart or Heart-Lung Transplants Who Received Cyclosporine
1985